[Studies of anti-inflammatory and analgesic activities of 3-(2-methoxy-ethyl)-2,3,4,5,7,12-hexahydro-1H-[1,2,5]triazepi no-[1,2-b]phthalazin 1,5-dion].
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy; D008297:Male; D010146:Pain / Q000188:drug therapy; D010793:Phthalazines / Q000627:therapeutic use*; D010998:Pleurisy / Q000188:drug therapy; D011724:Pyridazines / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010793:Phthalazines; D011724:Pyridazines; C054039:3-(2-methoxy-ethyl)-2,3,4,5,7,12-hexahydro-1H-(1,2,5)triazepino(1,2-b)phthalazin-1,5-dione
Badania aktywności przeciwzapalnej i przeciwbólowej 3-(2-metoksy-etylo)-2,3,4,5,7,12-heksahydro-1h-[1,2,5]triazepino-[1,2- b]ftalazyno 1,5-dionu.